Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization

Abstract

Candida albicans colonization is required for invasive disease1,2,3. Unlike humans, adult mice with mature intact gut microbiota are resistant to C. albicans gastrointestinal (GI) colonization2,4, but the factors that promote C. albicans colonization resistance are unknown. Here we demonstrate that commensal anaerobic bacteria—specifically clostridial Firmicutes (clusters IV and XIVa) and Bacteroidetes—are critical for maintaining C. albicans colonization resistance in mice. Using Bacteroides thetaiotamicron as a model organism, we find that hypoxia-inducible factor-1α (HIF-1α), a transcription factor important for activating innate immune effectors, and the antimicrobial peptide LL-37 (CRAMP in mice) are key determinants of C. albicans colonization resistance. Although antibiotic treatment enables C. albicans colonization, pharmacologic activation of colonic Hif1a induces CRAMP expression and results in a significant reduction of C. albicans GI colonization and a 50% decrease in mortality from invasive disease. In the setting of antibiotics, Hif1a and Camp (which encodes CRAMP) are required for B. thetaiotamicron–induced protection against C. albicans colonization of the gut. Thus, modulating C. albicans GI colonization by activation of gut mucosal immune effectors may represent a novel therapeutic approach for preventing invasive fungal disease in humans.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Gastrointestinal colonization levels of Candida spp. in antibiotic-treated adult, germ-free adult mice and in infant to adolescent mice.
Figure 2: Clostridial Firmicutes and Bacteroidetes promote C. albicans GI colonization resistance.
Figure 3: B. theta induces Hif1a and Camp in mouse colons.
Figure 4: L-mimosine–dependent activation of HIf1a and Camp in vivo decreases C. albicans GI colonization and dissemination.

References

  1. 1

    Miranda, L.N. et al. Candida colonisation as a source for candidaemia. J. Hosp. Infect. 72, 9–16 (2009).

  2. 2

    Nucci, M. & Anaissie, E. Revisiting the source of candidemia: skin or gut? Clin. Infect. Dis. 33, 1959–1967 (2001).

  3. 3

    Pizzo, P.A. & Poplack, D. (eds.) Principles and Practice of Pediatric Oncology, 6th Edition 1531 (Lippincott Williams & Wilkins, Philadelphia, 2011).

  4. 4

    Koh, A.Y., Kohler, J.R., Coggshall, K.T., Van Rooijen, N. & Pier, G.B. Mucosal damage and neutropenia are required for Candida albicans dissemination. PLoS Pathog. 4, e35 (2008).

  5. 5

    Iliev, I.D. et al. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 336, 1314–1317 (2012).

  6. 6

    Samonis, G. et al. Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans. Antimicrob. Agents Chemother. 37, 51–53 (1993).

  7. 7

    van der Waaij, D. Colonization resistance of the digestive tract: clinical consequences and implications. J. Antimicrob. Chemother. 10, 263–270 (1982).

  8. 8

    Lawley, T.D. & Walker, A.W. Intestinal colonization resistance. Immunology 138, 1–11 (2013).

  9. 9

    Berg, R.D. Promotion of the translocation of enteric bacteria from the gastrointestinal tracts of mice by oral treatment with penicillin, clindamycin, or metronidazole. Infect. Immun. 33, 854–861 (1981).

  10. 10

    Wang, Y. et al. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J. 3, 944–954 (2009).

  11. 11

    Ley, R.E. et al. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA 102, 11070–11075 (2005).

  12. 12

    Ringel-Kulka, T. et al. Intestinal microbiota in healthy U.S. young children and adults–a high-throughput microarray analysis. PLoS ONE 8, e64315 (2013).

  13. 13

    Garrod, L.P. The relative antibacterial activity of four penicillins. BMJ 2, 1695–1696 (1960).

  14. 14

    Nizet, V. & Johnson, R.S. Interdependence of hypoxic and innate immune responses. Nat. Rev. Immunol. 9, 609–617 (2009).

  15. 15

    Peyssonnaux, C. et al. HIF-1α expression regulates the bactericidal capacity of phagocytes. J. Clin. Invest. 115, 1806–1815 (2005).

  16. 16

    López-Garcia, B., Lee, P.H., Yamasaki, K. & Gallo, R.L. Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection. J. Invest. Dermatol. 125, 108–115 (2005).

  17. 17

    Tsai, P.W., Yang, C.Y., Chang, H.T. & Lan, C.Y. Human antimicrobial peptide LL-37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates. PLoS ONE 6, e17755 (2011).

  18. 18

    Atarashi, K. et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500, 232–236 (2013).

  19. 19

    Smith, P.M. et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569–573 (2013).

  20. 20

    Cummings, J.H., Pomare, E.W., Branch, W.J., Naylor, C.P. & Macfarlane, G.T. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28, 1221–1227 (1987).

  21. 21

    Zinkernagel, A.S., Peyssonnaux, C., Johnson, R.S. & Nizet, V. Pharmacologic augmentation of hypoxia-inducible factor-1α with mimosine boosts the bactericidal capacity of phagocytes. J. Infect. Dis. 197, 214–217 (2008).

  22. 22

    Argimón, S., Fanning, S., Blankenship, J.R. & Mitchell, A.P. Interaction between the Candida albicans high-osmolarity glycerol (HOG) pathway and the response to human β-defensins 2 and 3. Eukaryot. Cell 10, 272–275 (2011).

  23. 23

    Evans, D.F. et al. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 29, 1035–1041 (1988).

  24. 24

    He, G. et al. Noninvasive measurement of anatomic structure and intraluminal oxygenation in the gastrointestinal tract of living mice with spatial and spectral EPR imaging. Proc. Natl. Acad. Sci. USA 96, 4586–4591 (1999).

  25. 25

    Odds, F.C. Molecular phylogenetics and epidemiology of Candida albicans. Future Microbiol. 5, 67–79 (2010).

  26. 26

    Bougnoux, M.E. et al. Multilocus sequence typing reveals intrafamilial transmission and microevolutions of Candida albicans isolates from the human digestive tract. J. Clin. Microbiol. 44, 1810–1820 (2006).

  27. 27

    Angebault, C. et al. Candida albicans is not always the preferential yeast colonizing humans: a study in Wayampi Amerindians. J. Infect. Dis. 208, 1705–1716 (2013).

  28. 28

    Xu, J. & Mitchell, T.G. Geographical differences in human oral yeast flora. Clin. Infect. Dis. 36, 221–224 (2003).

  29. 29

    Guarner, F. & Malagelada, J.R. Gut flora in health and disease. Lancet 361, 512–519 (2003).

  30. 30

    Beaugerie, L. & Petit, J.C. Microbial-gut interactions in health and disease. Antibiotic-associated diarrhoea. Best Pract. Res. Clin. Gastroenterol. 18, 337–352 (2004).

  31. 31

    Vedantam, G. & Hecht, D.W. Antibiotics and anaerobes of gut origin. Curr. Opin. Microbiol. 6, 457–461 (2003).

  32. 32

    Cash, H.L., Whitham, C.V., Behrendt, C.L. & Hooper, L.V. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313, 1126–1130 (2006).

  33. 33

    Hooper, L.V., Stappenbeck, T.S., Hong, C.V. & Gordon, J.I. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat. Immunol. 4, 269–273 (2003).

  34. 34

    Mazmanian, S.K., Liu, C.H., Tzianabos, A.O. & Kasper, D.L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122, 107–118 (2005).

  35. 35

    Zwolińska-Wcisło, M. et al. Are probiotics effective in the treatment of fungal colonization of the gastrointestinal tract? Experimental and clinical studies. J. Physiol. Pharmacol. 57 (suppl. 9), 35–49 (2006).

  36. 36

    Kühbacher, T. et al. Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut 55, 833–841 (2006).

  37. 37

    Manzoni, P. et al. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin. Infect. Dis. 42, 1735–1742 (2006).

  38. 38

    Hatakka, K. et al. Probiotics reduce the prevalence of oral Candida in the elderly–a randomized controlled trial. J. Dent. Res. 86, 125–130 (2007).

  39. 39

    Semenza, G.L. Development of novel therapeutic strategies that target HIF-1. Expert Opin. Ther. Targets 10, 267–280 (2006).

  40. 40

    Zarember, K.A. & Malech, H.L. HIF-1α: a master regulator of innate host defenses? J. Clin. Invest. 115, 1702–1704 (2005).

  41. 41

    Goodman, A.L. et al. Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc. Natl. Acad. Sci. USA 108, 6252–6257 (2011).

  42. 42

    Goodman, A.L. et al. Identifying genetic determinants needed to establish a human gut symbiont in its habitat. Cell Host Microbe 6, 279–289 (2009).

  43. 43

    Ghannoum, M.A. et al. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog. 6, e1000713 (2010).

  44. 44

    Barman, M. et al. Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract. Infect. Immun. 76, 907–915 (2008).

  45. 45

    Claesson, M.J. et al. Comparison of two next-generation sequencing technologies for resolving highly complex microbiota composition using tandem variable 16S rRNA gene regions. Nucleic Acids Res. 38, e200 (2010).

  46. 46

    Caporaso, J.G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7, 335–336 (2010).

Download references

Acknowledgements

We would like to thank K. Nickerson (University of Nebraska, Lincoln, Nebraska), J. Patton-Vogt (Duquesne University, Pittsburgh, Pennsylvania), R. Wheeler (University of Maine, Orono, Maine) and M. Lorenz (University of Texas Health Science Center, Houston, Texas) for providing the C. albicans strains SN152 (from K. Nickerson), BWP17 (from J.Patton-Vogt), Can098 (from R. Wheeler), WO-1 (from M. Lorenz), 3153A (from M. Lorenz); C. Doern (Children's Medical Center Dallas, Dallas, Texas) for the C. glabrata, C. parapsilosis and C. tropicalis strains; and Y. Iwakura (Institute of Medical Science, Tokyo University, Tokyo, Japan) and J. Kolls (Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania) for the IL-17A–knockout mice. We would like to thank S. Skapek, J. Amatruda, R. DeBerardinis and D. Greenberg for providing helpful comments on the manuscript. This study was supported by the Roberta I. and Norman L. Pollock Fund (A.Y.K.), the Global Probiotics Council Young Investigator Grant for Probiotics (A.Y.K.), US National Institutes of Health (NIH) grant R01 DK060855 (L.V.H.), the Howard Hughes Medical Institute (L.V.H.) and NIH grant P30CA142543 (Y.X.).

Author information

A.Y.K. and L.V.H. conceived and designed the experiments. L.V.H. provided gnotobiotic mice and mucosal immunology instruction and support. A.Y.K., D.F., L.A.C., T.R.S.-W. and M.M.N. performed the experiments. A.Y.K., J.K., M.K., X.Z. and Y.X. conducted microbial profiling and statistical analysis. A.Y.K. and L.V.H. analyzed the data. A.Y.K. wrote the paper.

Correspondence to Andrew Y Koh.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–10 & Supplementary Tables 1–4 (PDF 10479 kb)

Source data

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Fan, D., Coughlin, L., Neubauer, M. et al. Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization. Nat Med 21, 808–814 (2015). https://doi.org/10.1038/nm.3871

Download citation

Further reading